Eli Lilly

Contact
lilly.com
+1-317-276-2000

Eli Lilly and Company

Lilly Corporate Center
46285 Indianapolis
USA
+1-317-276-2000
lilly.com
Contact
Profile Products News
Contact

About Eli Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first in class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

Read more about Eli Lilly
Facts about Eli Lilly
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Eli Lilly

Product portfolio

Show all

News about Eli Lilly

Eli Lilly

20-Nov-2023 | manufacturing

Lilly to expand injectable manufacturing capacity with planned $2.5 billion site in Germany

Company also commits to investing up to $100 million in German early-stage life sciences ecosystem

Read news
Eli Lilly

19-Jul-2022 | business & finance

Triastek announces research collaboration with Lilly

Application of 3D printing technology in oral delivery of drugs

Read news
Eli Lilly

19-Jan-2022 | business & finance

Evotec and Lilly enter into drug discovery collaboration in metabolic diseases

Lilly has the right to select up to five programmes

Read news
Eli Lilly

19-Oct-2017 | research and development

Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines

CureVac to receive an upfront payment of $50 million and an equity investment of €45 million

Read news
Eli Lilly

25-Feb-2016 | science

Major pharma companies sign up to groundbreaking Parkinson's consortium

Seven of the world's largest pharmaceutical companies have signed up to a groundbreaking consortium aimed at accelerating the development of safe and ...

Read news
Eli Lilly

08-Jul-2014 | business & finance

Yabao Pharmaceuticals Enters Partnership with Eli Lilly and Company to Develop Diabetes Treatment

Yabao Pharmaceutical Co, Inc.  announced a strategic partnership with Eli Lilly and Company to co-develop Lilly's leading glucokinase activator (GKA), ...

Read news
Eli Lilly

27-Oct-2011 | research and development

Lilly Announces Withdrawal of Xigris Following Recent Clinical Trial Results

Eli Lilly and Company announced withdrawal of its Xigris® [drotrecogin alfa (activated)] product in all markets following results of the PROWESS-SHOCK ...

Read news
Eli Lilly

15-Sep-2011 | business & finance

Lilly Invests $30 Million in Partnership to Address Non-Communicable Diseases

The Lilly NCD Partnership will seek innovative solutions to help fight chronic diseases in developing countries

Read news
Show more news about Eli Lilly

Here you will find Eli Lilly and Company